FOCAL POINTS (Courageous Discourse)

FOCAL POINTS (Courageous Discourse)

Antiviral Therapy for Monkeypox

Contemporary Review Highlights Advances in Treatment

Peter A. McCullough, MD, MPH's avatar
Peter A. McCullough, MD, MPH
Sep 02, 2024
∙ Paid
Upgrade to paid to play voiceover

By Peter A. McCullough, MD, MPH

With the current Monkeypox Public Health Emergency of International Concern declared by the WHO, a lead organization in the Bio-Pharmaceutical Complex, questions are coming in on how to treat a case of Monkeypox if it was recognized in a gay or bisexual man with the characteristic pox lesions around the anus or buttocks or mouth.

Pourkarim and Entezari-Maleki reviewed three antivirals that have had clinical use in the syndrome. The best-known is FDA approved tecovirimat which is available orally and intravenously.

User's avatar

Continue reading this post for free, courtesy of Peter A. McCullough, MD, MPH.

Or purchase a paid subscription.
© 2026 Peter McCullough MD MPH · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture